- Home
- MRK vs UBS Comparison
MRK vs UBS Comparison
Compare MRK & UBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MRK | UBS |
|---|---|---|
| Founded | 2000 | 1862 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 281.2B | 154.1B |
| IPO Year | 1994 | 2014 |
Fundamental Metrics
Financial Performance| Metric | MRK | UBS |
|---|---|---|
| Price | $128.34 | $49.17 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 17 | 2 |
| Target Price | ★ $125.59 | $60.30 |
| AVG Volume (30 Days) | ★ 8.6M | 2.2M |
| Earning Date | 04-30-2026 | 04-29-2026 |
| Dividend Yield | ★ 3.06% | 1.29% |
| EPS Growth | ★ 8.01 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $65,011,000,000.00 | N/A |
| Revenue This Year | $3.61 | $7.40 |
| Revenue Next Year | $5.41 | $2.83 |
| P/E Ratio | ★ N/A | $17.22 |
| Revenue Growth | ★ 1.31 | N/A |
| 52 Week Low | $76.66 | $33.48 |
| 52 Week High | $125.96 | $51.24 |
Technical Indicators
Market Signals| Indicator | MRK | UBS |
|---|---|---|
| Relative Strength Index (RSI) | 70.38 | 54.32 |
| Support Level | $112.68 | $46.47 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 3.07 | 0.79 |
| MACD | 0.91 | -0.11 |
| Stochastic Oscillator | 97.44 | 50.78 |
Price Performance
Historical ComparisonAbout MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
About UBS UBS Group AG Registered
UBS is a global financial institution built around its core strength in wealth management, serving high and ultra-high-net-worth individuals. In Switzerland, it also operates as a traditional retail and commercial bank. Its investment bank and asset management divisions complement the wealth business, providing tailored solutions to UBS clients while serving third-party customers by leveraging UBS' global reach and expertise.